{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:04:38Z","timestamp":1785855878936,"version":"3.56.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ejps.2024.106885","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T22:19:47Z","timestamp":1724451587000},"page":"106885","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Effect of protein binding on the pharmacokinetics of the six substrates in the Basel phenotyping cocktail in healthy subjects and patients with liver cirrhosis"],"prefix":"10.1016","volume":"202","author":[{"given":"Urs","family":"Duthaler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Chapuisat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Hanimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8347-4145","authenticated-orcid":false,"given":"Stephan","family":"Kr\u00e4henb\u00fchl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2024.106885_bib0001","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/clpt.1982.65","article-title":"Effects of total plasma concentration and age on tolbutamide plasma protein binding","volume":"31","author":"Adir","year":"1982","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2024.106885_bib0002","doi-asserted-by":"crossref","first-page":"4608","DOI":"10.1111\/bcp.14874","article-title":"Effect of deglucuronidation on the results of the Basel phenotyping cocktail","volume":"87","author":"Bachmann","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2024.106885_bib0003","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3389\/fphar.2018.00774","article-title":"Cytochrome P450 enzymes involved in metoprolol metabolism and use of metoprolol as a CYP2D6 phenotyping probe drug","volume":"9","author":"Berger","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejps.2024.106885_bib0004","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s40262-021-01028-8","article-title":"Effect of liver cirrhosis on the pharmacokinetics, metabolism, and tolerability of daridorexant, a novel dual orexin receptor antagonist","volume":"60","author":"Berger","year":"2021","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2024.106885_bib0005","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1046\/j.1365-2125.2003.01973.x","article-title":"Pharmacokinetic and pharmacodynamic assessment of a five-probe metabolic cocktail for CYPs 1A2, 3A4, 2C9, 2D6 and 2E1","volume":"57","author":"Blakey","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2024.106885_bib0006","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/bcpt.12231","article-title":"Incorporation of flurbiprofen in a 4-drug cytochrome p450 phenotyping cocktail","volume":"115","author":"Bosilkovska","year":"2014","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejps.2024.106885_bib0007","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ijpharm.2016.08.043","article-title":"CombiCap, a novel drug formulation for the Basel phenotyping cocktail","volume":"512","author":"Camblin","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2024.106885_bib0008","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/j.1552-4604.1995.tb04097.x","article-title":"Human plasma protein binding of the angiotensin II receptor antagonist losartan potassium (DuP 753\/MK 954) and its pharmacologically active metabolite EXP3174","volume":"35","author":"Christ","year":"1995","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2024.106885_bib0009","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/hep.1840010617","article-title":"A peek at the Child-Turcotte classification","volume":"1","author":"Conn","year":"1981","journal-title":"Hepatology"},{"key":"10.1016\/j.ejps.2024.106885_bib0010","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2165\/00003088-199733030-00003","article-title":"Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls","volume":"33","author":"Davies","year":"1997","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2024.106885_bib0011","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s40262-015-0294-y","article-title":"Effects of cytochrome P450 inhibition and induction on the phenotyping metrics of the Basel cocktail: a randomized crossover study","volume":"55","author":"Derungs","year":"2016","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2024.106885_bib0012","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40262-013-0115-0","article-title":"The Basel cocktail for simultaneous phenotyping of human cytochrome P450 isoforms in plasma, saliva and dried blood spots","volume":"53","author":"Donzelli","year":"2014","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2024.106885_bib0013","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1749-6632.1984.tb14507.x","article-title":"Clinical consequences of the lipophilicity and plasma protein binding of antiarrhythmic drugs and active metabolites in man","volume":"432","author":"Drayer","year":"1984","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejps.2024.106885_bib0014","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s40262-023-01261-3","article-title":"The activity of members of the UDP-glucuronosyltransferase subfamilies UGT1A and UGT2B is impaired in patients with liver cirrhosis","volume":"62","author":"Duthaler","year":"2023","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2024.106885_bib0015","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s40262-022-01119-0","article-title":"Liver cirrhosis affects the pharmacokinetics of the six substrates of the Basel phenotyping cocktail differently","volume":"61","author":"Duthaler","year":"2022","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2024.106885_bib0016","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/sj.clpt.6100050","article-title":"Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the \"cocktail\" approach","volume":"81","author":"Fuhr","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2024.106885_bib0017","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1124\/dmd.115.068908","article-title":"Stereoselective glucuronidation of bupropion metabolites in vitro and in vivo","volume":"44","author":"Gufford","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2024.106885_bib0018","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/11318160-000000000-00000","article-title":"A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance","volume":"49","author":"Johnson","year":"2010","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2024.106885_bib0019","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.2174\/1381612823666170207100724","article-title":"In vivo phenotyping methods: cytochrome P450 probes with emphasis on the cocktail approach","volume":"23","author":"Keller","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejps.2024.106885_bib0020","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejps.2024.106885_bib0021","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.clpt.2006.03.010","article-title":"Cytochrome P450 2B6 activity as measured by bupropion hydroxylation: effect of induction by rifampin and ethnicity","volume":"80","author":"Loboz","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2024.106885_bib0022","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.dmpk.2019.12.004","article-title":"Recent progress in in vivo phenotyping technologies for better prediction of transporter-mediated drug-drug interactions","volume":"35","author":"Maeda","year":"2020","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ejps.2024.106885_bib0023","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/cpt.2897","article-title":"Dose adjustment in patients with liver cirrhosis - comparison of two different modeling approaches","volume":"113","author":"Ozbey","year":"2023","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2024.106885_bib0024","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/00498254.2017.1354267","article-title":"Quantitative in vitro phenotyping and prediction of drug interaction potential of CYP2B6 substrates as victims","volume":"48","author":"Palacharla","year":"2018","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ejps.2024.106885_bib0025","first-page":"36","article-title":"[Foreign substances as indicators of liver function]","volume":"19","author":"Preisig","year":"1985","journal-title":"Schweiz. Med. Wochenschr. Suppl."},{"key":"10.1016\/j.ejps.2024.106885_bib0026","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/hep.1840140316","article-title":"Accurate prediction of death by serial determination of galactose elimination capacity in primary biliary cirrhosis: a comparison with the Mayo model","volume":"14","author":"Reichen","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.ejps.2024.106885_bib0027","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1124\/dmd.116.072363","article-title":"Stereoselective metabolism of bupropion to OH-bupropion, threohydrobupropion, erythrohydrobupropion, and 4\u2032-OH-bupropion in vitro","volume":"44","author":"Sager","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2024.106885_bib0028","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s40262-015-0288-9","article-title":"A prediction model of drug exposure in cirrhotic patients according to child-pugh classification","volume":"54","author":"Steelandt","year":"2015","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2024.106885_bib0029","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/bcp.14157","article-title":"Pharmacokinetics and phenotyping properties of the Basel phenotyping cocktail combination capsule in healthy male adults","volume":"86","author":"Suenderhauf","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2024.106885_bib0030","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1365-2710.2003.00486.x","article-title":"How useful is the \"cocktail approach\" for evaluating human hepatic drug metabolizing capacity using cytochrome P450 phenotyping probes in vivo?","volume":"28","author":"Tanaka","year":"2003","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.ejps.2024.106885_bib0031","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/cpt.1564","article-title":"A clinical drug-drug interaction study assessing a novel drug transporter phenotyping cocktail with adefovir, sitagliptin, metformin, pitavastatin, and digoxin","volume":"106","author":"Trueck","year":"2019","journal-title":"Clin. Pharmacol. Therap."},{"key":"10.1016\/j.ejps.2024.106885_bib0032","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.clpt.2005.02.010","article-title":"Effect of clopidogrel and ticlopidine on cytochrome P450 2B6 activity as measured by bupropion hydroxylation","volume":"77","author":"Turpeinen","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2024.106885_bib0033","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/cpt1976195part1552","article-title":"Serum protein binding as a determinant of warfarin body clearance and anticoagulant effect","volume":"19","author":"Yacobi","year":"1976","journal-title":"Clin. Pharmacol. Ther."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724001970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724001970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T03:21:00Z","timestamp":1726629660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098724001970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":33,"alternative-id":["S0928098724001970"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106885","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of protein binding on the pharmacokinetics of the six substrates in the Basel phenotyping cocktail in healthy subjects and patients with liver cirrhosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106885","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106885"}}